See also this year's filing and all EDGAR filings for this company.
PDF Report 0001796129_2023_Vincerx_Pharma_Inc.pdf
Logs
Graph
Absolute values for 0001796129, Vincerx Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,964,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 177,000 |
| 3 | remainder_Assets | 3,145,000 |
| 4 | LiabilitiesCurrent | 9,156,000 |
| 5 | LiabilitiesNoncurrent | 2,462,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,953,000 |
| 9 | ResearchAndDevelopmentExpense | 52,152,000 |
| 10 | remainder_Expenses | 2,469,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 8,207,000 |
| 13 | remainder_ComprehensiveNetIncome | -5,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 59,286,000 |
| 1 | Liabilities | 11,618,000 |
| 2 | Expenses | 73,574,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 47,668,000 |
| 5 | NetIncome | -65,367,000 |
| 6 | ComprehensiveNetIncome | -65,369,500 |
| 7 | BaseVar | 76,345,000 |
| 8 | EconomicCapitalRatio | 0.469 |
Edgar->Model Mapping
Feature Distribution
Change over Time
